News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elvina Almuradova: Reasearch shows radioactive iodine increases skin cancer risk in thyroid cancer patients
Elvina Almuradova/X
Oct 23, 2024, 12:18

Elvina Almuradova: Reasearch shows radioactive iodine increases skin cancer risk in thyroid cancer patients

Elvina Almuradova, Associate Professor at Medicana Health Group, shared the following post on LinkedIn:

“Research by Rezaei et al. in JAMA Network Open shows elevated risk of melanoma and other skin cancers in thyroid cancer patients treated with radioactive iodine.

Data: Analysis included 174,916 thyroid cancer patients from SEER registries (2000-2019).

Findings:

  • Radioactive iodine increases skin cancer risk:
  • All nonkeratinocyte skin cancers: SIR = 1.42
  • Melanoma: SIR = 1.38
  • Other nonkeratinocyte cancers: SIR = 2.02
  • Highest risk for cancers of the head and neck:
  • Nonkeratinocyte cancers: SIR = 1.64
  • Melanoma: SIR = 1.56
  • Papillary Thyroid Cancer: Higher skin cancer risk seen in patients treated with radiation (SIR = 1.69).

Given the elevated risk highlighted in the study, regular skin checks and dermatologic surveillance are essential, especially for areas such as the head and neck!”

Development of Melanoma and Other Nonkeratinocyte Skin Cancers After Thyroid Cancer Radiation

Authors: Shawheen J. Rezaei, Michael L. Chen, Jiyeong Kim, Esther M. John, John B. Sunwoo, Eleni Linos.

Elvina Almuradova: Reasearch shows radioactive iodine increases skin cancer risk in thyroid cancer patients

cancer Eleni Linos Elvina Almuradova Esther M. John JAMA Network Open Jiyeong Kim John B. Sunwoo Melanoma Michael L. Chen OncoDaily Oncology radioactive iodine Rezaei et al. SEER registries Shawheen J. Rezaei skin cancer thyroid cancer
Special Coverage
Blog
May 4, 2025, 02:03
Greisha Lee Ortíz-Hernández: I am honored to belong to a scientific community that thrives and lifts each other up
Blog
May 4, 2025, 01:51
AACR25 Clinical Trials plenary highlights advances in expanding Immunotherapy access
Blog
May 4, 2025, 01:46
Maryam Lustberg: Chroninc neuropathy is a toxicity that we need to help mitigate in every way possible
Blog
May 4, 2025, 01:38
Lauren Henke highlights NRG Oncology Podcast on pancreatic cancer research and RTOG 0848
Blog
May 4, 2025, 01:29
Aparna Parikh: Excited to be a part of Parithera's team
Blog
May 4, 2025, 01:19
Gregg Margolis: Key health policy reads of the week
Blog
May 4, 2025, 01:06
Protect cancer research programs at HHS – ACS CAN urges reversal of FY26 budget cuts
Blog
May 4, 2025, 00:55
Wafik S. El-Deiry: Important Legorreta Cancer Center leadership advisory group meeting with updates on NIH and NCI news
Blog
May 4, 2025, 00:42
Peter Pisters: It was great to join MD Anderson Cancer Center's Leadership Institute External Advisory Board Meeting
Insight
May 4, 2025, 00:23
Maryam Lustberg: Barriers and Opportunities for Cancer Clinical Trials in Low- and Middle-Income Countries
Blog
May 3, 2025, 23:01
Qing Zhang reflects on AACR25 grantee reception with colleagues and mentors
Science
May 3, 2025, 22:01
International consensus on laryngeal preservation strategies in laryngeal and hypopharyngeal cancer